Your browser doesn't support javascript.
loading
Body mass index and breast cancer survival: a Mendelian randomization analysis.
Guo, Qi; Burgess, Stephen; Turman, Constance; Bolla, Manjeet K; Wang, Qin; Lush, Michael; Abraham, Jean; Aittomäki, Kristiina; Andrulis, Irene L; Apicella, Carmel; Arndt, Volker; Barrdahl, Myrto; Benitez, Javier; Berg, Christine D; Blomqvist, Carl; Bojesen, Stig E; Bonanni, Bernardo; Brand, Judith S; Brenner, Hermann; Broeks, Annegien; Burwinkel, Barbara; Caldas, Carlos; Campa, Daniele; Canzian, Federico; Chang-Claude, Jenny; Chanock, Stephen J; Chin, Suet-Feung; Couch, Fergus J; Cox, Angela; Cross, Simon S; Cybulski, Cezary; Czene, Kamila; Darabi, Hatef; Devilee, Peter; Diver, W Ryan; Dunning, Alison M; Earl, Helena M; Eccles, Diana M; Ekici, Arif B; Eriksson, Mikael; Evans, D Gareth; Fasching, Peter A; Figueroa, Jonine; Flesch-Janys, Dieter; Flyger, Henrik; Gapstur, Susan M; Gaudet, Mia M; Giles, Graham G; Glendon, Gord; Grip, Mervi.
Afiliação
  • Guo Q; Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Burgess S; Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Turman C; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
  • Bolla MK; Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Lush M; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Abraham J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Aittomäki K; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Andrulis IL; Cambridge Experimental Cancer Medicine Centre, Cambridge, UK.
  • Apicella C; Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Arndt V; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada.
  • Barrdahl M; Department of Molecular Genetics, University of Toronto, Toronto, Canada.
  • Benitez J; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia.
  • Berg CD; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Blomqvist C; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Bojesen SE; Human Cancer Genetics Program, Spanish National Cancer Research Centre, Madrid, Spain.
  • Bonanni B; Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain.
  • Brand JS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Brenner H; Department of Oncology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Broeks A; Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Burwinkel B; Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Caldas C; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia, Milan, Italy.
  • Campa D; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Canzian F; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Chang-Claude J; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
  • Chanock SJ; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Chin SF; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Couch FJ; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany.
  • Cox A; Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Cross SS; Cambridge Experimental Cancer Medicine Centre, Cambridge, UK.
  • Cybulski C; Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Cambridge, UK.
  • Czene K; Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, UK.
  • Darabi H; Department of Biology, University of Pisa, Pisa, Italy.
  • Devilee P; Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Diver WR; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Dunning AM; University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Earl HM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
  • Eccles DM; Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, UK.
  • Ekici AB; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Eriksson M; Academic Unit of Molecular Oncology, Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
  • Evans DG; Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, UK.
  • Fasching PA; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Figueroa J; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Flesch-Janys D; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Flyger H; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Gapstur SM; Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
  • Gaudet MM; Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA.
  • Giles GG; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  • Glendon G; Cambridge Experimental Cancer Medicine Centre, Cambridge, UK.
  • Grip M; Cambridge Breast Unit and NIHR Cambridge Biomedical Research Centre, University of Cambridge NHS Foundation Hospitals, Cambridge, UK.
Int J Epidemiol ; 46(6): 1814-1822, 2017 12 01.
Article em En | MEDLINE | ID: mdl-29232439
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores de Estrogênio / Índice de Massa Corporal / População Branca Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans País/Região como assunto: Europa Idioma: En Revista: Int J Epidemiol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Receptores de Estrogênio / Índice de Massa Corporal / População Branca Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies / Systematic_reviews Limite: Female / Humans País/Região como assunto: Europa Idioma: En Revista: Int J Epidemiol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido